Closing Remarks Podcast: Becca Brown on Can AI Fuel Growth?
Can you use AI to grow your business, launch new products, cut costs, and grow faster? How can you ensure your business will be valuable when it's time to sell?
Closing Remarks Podcast: Doug Kintzinger on Strategic Acquisitions
What makes a business an attractive acquisition opportunity? Is it financial performance, growth potential, or something buyers see beyond the numbers?
Closing Remarks Podcast: Ed Mitzen On Culture That Scales
Your business is growing. Your team is expanding. Revenue is climbing. But here's a question worth asking: Is your company culture keeping up?
Benchmark International Successfully Facilitated the Transaction Between T.S.G. Associates LLP and Protect Medical Group
Benchmark International is pleased to announce the acquisition of TSG by Protect Medical.
Irish Budget 2027: What Business Owners Need to Know Before a Sale, Acquisition, or Growth Journey
The Irish Government's Budget 2027 introduced several measures aimed at supporting entrepreneurship, investment and business growth. While much of the media focus has been on personal taxation changes, three announcements stand out for privately owned businesses and shareholders considering growth, investment or an eventual exit.
The Future of Healthcare & Life Sciences M&A
Market Forces and Investor Interest
Benchmark International Successfully Facilitated the Transaction Between Colibri Scientific Limited and Biofortuna Ltd
Benchmark International is proud to announce the acquisition of Colibri Scientific by Biofortuna.
Benchmark International is Still #1 in the World
Benchmark International remains the world’s #1 privately owned sell-side M&A advisor, based on PitchBook’s Q2 2026 Global League Tables. Benchmark International also ranks:
Other Healthcare Industry Report
There is a growing number of patients around the world who need various healthcare offerings due to the increasing prevalence of acute and chronic diseases, such as diabetes and cancer, alongside growing awareness surrounding treatment options. Market expansion in the “other healthcare” sector will continue as the number of surgical procedures, including cardiac, orthopedic, and neurological interventions, rises. The rise in surgical and diagnostic procedures is fueling demand for products, including equipment and consumables. R&D initiatives by key market players to develop novel equipment to meet the growing demand for novel devices are supporting global industry activity.
Closing Remarks Podcast: Josh Weis on Culture & Winning
What separates companies that outperform their competitors? In this episode of Closing Remarks, host Dara Shareef sits down with Josh Weis, CEO of Vehlo, to talk about how to use data to drive better decisions and build a people-centered winning culture.